Cargando…
The B-VITAGE trial: A randomized trial of homocysteine lowering treatment of depression in later life
BACKGROUND: Depression is a leading cause of disability worldwide and depressive symptoms are common in later life. Observational evidence suggests that depression is more prevalent among people with high plasma homocysteine (tHcy), but the results of randomized trials to date have been unable to sh...
Autores principales: | Ford, Andrew H, Flicker, Leon, McCaul, Kieran, van Bockxmeer, Frank, Hegarty, Sarah, Hirani, Varsha, Fenner, Stephen, Almeida, Osvaldo P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822769/ https://www.ncbi.nlm.nih.gov/pubmed/20096138 http://dx.doi.org/10.1186/1745-6215-11-8 |
Ejemplares similares
-
The B-VITAGE trial: A randomized trial of homocysteine lowering treatment of depression in later life
por: Ford, Andrew H, et al.
Publicado: (2011) -
Aspirin decreases the risk of depression in older men with high plasma homocysteine
por: Almeida, O P, et al.
Publicado: (2012) -
Reducing depression during the menopausal transition: study protocol for a randomised controlled trial
por: Almeida, Osvaldo P, et al.
Publicado: (2014) -
Cognitive bias modification to prevent depression (COPE): study protocol for a randomised controlled trial
por: Almeida, Osvaldo P, et al.
Publicado: (2014) -
Affective Disorders, Psychosis and Dementia in a Community Sample of Older Men with and without Parkinson’s Disease
por: Almeida, Osvaldo P., et al.
Publicado: (2016)